Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended?

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|137|2|420-427

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.2, 2015-07, pp. : 420-427

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human papillomavirus vaccination and screening as the new paradigm in cervical cancer prevention

By Franco Eduardo L Paavonen Jorma

Therapy, Vol. 5, Iss. 3, 2008-05 ,pp. : 261-263

Future Medicine

Access to resources Recommend Favorite

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, Vol. 39, Iss. 2, 2015-04 ,pp. : 153-156

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interim Guidelines Describe Using High‐Risk Human Papillomavirus Testing as Alternative for Primary Cervical Cancer Screening

JOURNAL OF MIDWIFERY & WOMEN'S HEALTH, Vol. 60, Iss. 3, 2015-05 ,pp. : 330-331

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human Papillomavirus DNA Testing for Cervical Cancer Screening: Practical Aspects in Developing Countries

By Belinson Suzanne E. Belinson Jerome L.

Molecular Diagnosis & Therapy, Vol. 14, Iss. 4, 2010-08 ,pp. : 215-222

Adis International

Access to resources Recommend Favorite

Human papillomavirus screening and vaccines for cancer prevention: what is on the horizon?

By Trimble Cornelia L Gravitt Patti Roden Richard BS

Therapy, Vol. 5, Iss. 3, 2008-05 ,pp. : 295-303

Future Medicine

Access to resources Recommend Favorite